In Brief: Glaxo Wellcome Ceftin tablets
Executive Summary
Glaxo Wellcome Ceftin tablets: Antibiotic cefuroxime is cleared March 11 for additional indication of acute bacterial maxillary sinusitis caused by Streptococcus pneumoniae and non-beta-lactamase-producing strains of Haemophilus influenzae. Recommended dose is 250 mg twice daily for 10 days, the same dose recommended for other respiratory infections. Ceftin tablets also are indicated in the treatment of pharyngitis/tonsillitis, otitis media, bronchitis, skin and skin structure infections, urinary tract infections and gonorrhea...